Shruti Lal et al provided evidence that posttranscriptional regulation of WEE1 by Hu antigen (HuR) is critical for human pancreatic ductal adenocarcinoma cell survival under clinically relevant drug exposure [50]. The gene discussed is ELAVL1; the disease is pancreatic ductal adenocarcinoma.